GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Other Net Income (Loss)

Genetron Holdings (Genetron Holdings) Other Net Income (Loss) : $-0.00 Mil (TTM As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Other Net Income (Loss)?

Genetron Holdings's Other Net Income (Loss) for the three months ended in Jun. 2022 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.00 Mil.

Genetron Holdings's quarterly Other Net Income (Loss) increased from Dec. 2021 ($-0.00 Mil) to Mar. 2022 ($-0.00 Mil) and increased from Mar. 2022 ($-0.00 Mil) to Jun. 2022 ($0.00 Mil).

Genetron Holdings's annual Other Net Income (Loss) declined from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.00 Mil).


Genetron Holdings Other Net Income (Loss) Historical Data

The historical data trend for Genetron Holdings's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Other Net Income (Loss) Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Net Income (Loss)
Get a 7-Day Free Trial - - - - -

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genetron Holdings Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.